{"bekendtgoerelseNoegle":{"noticeId":{"value":"05bba3f0-aa33-431a-b47f-d4d8252fbac2"},"noticeVersion":{"value":"01"},"noticePublicationNumber":{"value":"00317424-2024"}},"htmlDA":"\n\n \n
1 Køber
1.1 Køber
Officielt navn: Aarhus Universitet
\n
Køberens retlige status: Offentligretligt organ
\n
Den ordregivende myndigheds aktiviteter: Uddannelse
\n
\n
\n
2 Procedure
2.1 Procedure
Titel: 2024-0666349 - Perifusion System
\n
Beskrivelse: The Department of Biomedicine at Aarhus University intends to buy the PERI5-115/230\n - AUTOMATED PERIFUSION SYSTEM for the reasons listed below. The PERI5-115/230 - AUTOMATED\n PERIFUSION SYSTEM instrumentation holds advanced features including high-resolution\n infusion capacity, real-time monitoring capabilities, customizable experimental setups,\n and compatibility with various laboratory protocols/assays. These specifications are\n crucial for our research and experimental endeavors, as they enable us to accurately\n measure and analyze physiological parameters with utmost precision and efficiency\n related to our research interests in studying kidney disease.The advanced specifications\n offered by the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation are necessary\n for our laboratory due to the intricate nature of our research projects and the critical\n need for reliable precise drug delivery or precise incubation conditions. Without\n these features, we would face significant limitations in our ability to accurately\n study and understand complex physiological phenomena, potentially impeding our progress\n and hindering the advancement of our scientific objectives.To the best of our knowledge,\n no alternative suppliers have come to our attention, the distinctive combination of\n features, quality, and expertise encapsulated in the PERI5-115/230 - AUTOMATED PERIFUSION\n SYSTEM instrumentation from Biorep Technologies, Inc. that can fulfil our needs. The\n conclusion drawn from our analysis is that, given the absence of viable alternatives\n known to us, Biorep Technologies, Inc. is the optimal and only choice to fulfil our\n requirements, providing us with the necessary tools and support to advance our research\n endeavours successfully.
\n
Identifikator for proceduren: fb84f75e-f84e-4ba2-bd14-66b9984b836c
\n
Tidligere bekendtgørelse: 4ddd65eb-1793-47d1-ad17-e9460e7de914-01
\n
Intern identifikator: 2024-0666349
\n
Udbudsprocedure: Udbud med forhandling uden forudgående offentliggørelse
\n
2.1.1 Formål
Kontraktens art: Varer
\n
Primær klassificering (cpv): 38000000 Laboratorieudstyr, optisk udstyr og præcisionsudstyr (ikke briller)
\n
Yderligere klassificering (cpv): 38432000 Analyseapparatur
\n
\n
2.1.2 Udførelsessted
Landespecifik underafdeling (NUTS): Østjylland (DK042)
\n
Land: Danmark
\n
\n
2.1.4 Generelle oplysninger
Indkaldelse af tilbud er afsluttet
\n
Retsgrundlag:
\n
Direktiv 2014/24/EU
\n
\n
\n
\n
5 Delkontrakt
5.1 Teknisk ID for partiet: LOT-0000
Titel: 2024-0666349 - Perifusion System
\n
Beskrivelse: The Department of Biomedicine at Aarhus University intends to buy the PERI5-115/230\n - AUTOMATED PERIFUSION SYSTEM for the reasons listed below. The PERI5-115/230 - AUTOMATED\n PERIFUSION SYSTEM instrumentation holds advanced features including high-resolution\n infusion capacity, real-time monitoring capabilities, customizable experimental setups,\n and compatibility with various laboratory protocols/assays. These specifications are\n crucial for our research and experimental endeavors, as they enable us to accurately\n measure and analyze physiological parameters with utmost precision and efficiency\n related to our research interests in studying kidney disease.The advanced specifications\n offered by the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation are necessary\n for our laboratory due to the intricate nature of our research projects and the critical\n need for reliable precise drug delivery or precise incubation conditions. Without\n these features, we would face significant limitations in our ability to accurately\n study and understand complex physiological phenomena, potentially impeding our progress\n and hindering the advancement of our scientific objectives.To the best of our knowledge,\n no alternative suppliers have come to our attention, the distinctive combination of\n features, quality, and expertise encapsulated in the PERI5-115/230 - AUTOMATED PERIFUSION\n SYSTEM instrumentation from Biorep Technologies, Inc. that can fulfil our needs. The\n conclusion drawn from our analysis is that, given the absence of viable alternatives\n known to us, Biorep Technologies, Inc. is the optimal and only choice to fulfil our\n requirements, providing us with the necessary tools and support to advance our research\n endeavours successfully.
\n
Intern identifikator: 2024-0666349
\n
5.1.1 Formål
Kontraktens art: Varer
\n
Primær klassificering (cpv): 38000000 Laboratorieudstyr, optisk udstyr og præcisionsudstyr (ikke briller)
\n
Yderligere klassificering (cpv): 38432000 Analyseapparatur
\n
\n
5.1.2 Udførelsessted
Landespecifik underafdeling (NUTS): Østjylland (DK042)
\n
Land: Danmark
\n
Yderligere oplysninger: 
\n
\n
5.1.4 Fornyelse
Højeste antal fornyelser: 0
\n
\n
5.1.6 Generelle oplysninger
Indkøbsprojekt, der ikke finansieres med EU-midler
\n
Udbuddet er omfattet af aftalen om offentlige udbud (GPA): ja
\n
\n
5.1.10 Tildelingskriterier
Kriterium:
Type: Kvalitet
\n
Beskrivelse: The instrument is unique
\n
Prioriteret rækkefølge: 1
\n
\n
Begrundelse for ikke at angive vægtningen af tildelingskriterierne: There is only one supplier of this instrument
\n
\n
5.1.12 Udbudsvilkår
Oplysninger om undersøgelsesfrister: Please contact Aarhus University, if you have a comment about this notice - udbud@au.dk\n Following the notification, a standstill period of 10 calendar days will be held in\n accordance to paragraph 3 of Act No. 593 of 2 June 2016 on the Danish Act on the Complaints\n Board for public Procurement. This implies that the Contracting Authority cannot sign\n the Contract with the winning Tenderer before the standstill period has expired. In\n case of complaints about tenders or decisions, e.g. award of contracts covered by\n Section II or III in the Danish Public Procurement Act must be submitted to the Complaints\n Board for Public Procurement (Klagenævnet for Udbud) within 45 calendar days from\n the day after the contractor published a notice in the Official Journal on the conclusion\n of a contract. At the latest concurrently with submission of an appeal to the Complaints\n Board for Public Procurement, the complainant must inform the Contracting Authority\n of the alleged infringement, and whether the appeal is to be referred to the board.
\n
\n
5.1.15 Teknikker
Rammeaftale:
Ingen rammeaftale
\n
\n
Oplysninger om det dynamiske indkøbssystem:
Intet dynamisk indkøbssystem
\n
\n
\n
5.1.16 Yderligere oplysninger, mægling og gennemgang
Organisation med ansvar for klager: Klagenævnet for udbud
\n
Organisation, der leverer yderligere oplysninger om klageprocedurerne: Konkurrence- og Forbrugerstyrelsen
\n
TED eSender: Mercell Holding ASA
\n
\n
\n
\n
6 Resultater
Værdien af alle kontrakter tildelt i denne meddelelse: 511.566 Dansk krone
\n
Direkte tildeling:
Begrundelse for direkte tildeling: Kontrakten kan kun tildeles af en bestemt økonomisk aktør på grund af manglende konkurrence af tekniske årsager
\n
Anden begrundelse: The Department of Biomedicine at Aarhus University intends to buy the PERI5-115/230\n - AUTOMATED PERIFUSION SYSTEM for the reasons listed below. The PERI5-115/230 - AUTOMATED\n PERIFUSION SYSTEM instrumentation holds advanced features including high-resolution\n infusion capacity, real-time monitoring capabilities, customizable experimental setups,\n and compatibility with various laboratory protocols/assays. These specifications are\n crucial for our research and experimental endeavors, as they enable us to accurately\n measure and analyze physiological parameters with utmost precision and efficiency\n related to our research interests in studying kidney disease.The advanced specifications\n offered by the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation are necessary\n for our laboratory due to the intricate nature of our research projects and the critical\n need for reliable precise drug delivery or precise incubation conditions. Without\n these features, we would face significant limitations in our ability to accurately\n study and understand complex physiological phenomena, potentially impeding our progress\n and hindering the advancement of our scientific objectives.To the best of our knowledge,\n no alternative suppliers have come to our attention, the distinctive combination of\n features, quality, and expertise encapsulated in the PERI5-115/230 - AUTOMATED PERIFUSION\n SYSTEM instrumentation from Biorep Technologies, Inc. that can fulfil our needs. The\n conclusion drawn from our analysis is that, given the absence of viable alternatives\n known to us, Biorep Technologies, Inc. is the optimal and only choice to fulfil our\n requirements, providing us with the necessary tools and support to advance our research\n endeavours successfully.
\n
\n
6.1 Resultat delkontrakt-ID: LOT-0000
Der er udvalgt mindst én vinder.
\n
6.1.2 Oplysninger om vinderne
Vinder:
Officielt navn: Biorep Technologies, Inc.
\n
Tilbud:
\n
Tilbud – Identifikator: 2024-0666349 - Perifusion System
\n
Identifikator for delkontrakt eller gruppe af delkontrakter: LOT-0000
\n
Underentreprise: Nej
\n
Underentrepriseværdien er kendt: nej
\n
Underentrepriseprocentdelen er kendt: nej
\n
Kontraktoplysninger:
Identifikator for kontrakten: 2024-0666349 - Perifusion System
\n
Dato for indgåelse af kontrakten: 14-05-2024
\n
Kontrakten tildeles som led i en rammeaftale: nej
\n
\n
\n
\n
6.1.4 Statistiske oplysninger
Modtagne tilbud og ansøgninger om deltagelse:
Type modtagne indgivelser: Tilbud fra mellemstore virksomheder
Antal modtagne tilbud og ansøgninger om deltagelse: 1
\n
\n
\n
\n
\n
\n
8 Organisationer
8.1 ORG-0001
Officielt navn: Aarhus Universitet
\n
Registreringsnummer: ORG-31119103
\n
Postadresse: Nordre Ringgade 1  
\n
By: Aarhus C
\n
Postnummer: 8000
\n
Landespecifik underafdeling (NUTS): Østjylland (DK042)
\n
Land: Danmark
\n
Kontaktpunkt: Ann Sophie Steffensen
\n
E-mail: asst@au.dk
\n
Telefon: 23382421
\n
Internetadresse: https://www.au.dk/
\n
Denne organisations roller:
Køber
\n
\n
\n
8.1 ORG-0002
Officielt navn: Klagenævnet for udbud
\n
Registreringsnummer: ORG-37795526
\n
Postadresse: Toldboden 2  
\n
By: Viborg
\n
Postnummer: 8800
\n
Landespecifik underafdeling (NUTS): Vestjylland (DK041)
\n
Land: Danmark
\n
Kontaktpunkt: Klagenævnet for udbud
\n
E-mail: klfu@naevneneshus.dk
\n
Telefon: +45 72405708
\n
Adresse til udveksling af oplysninger (URL): https://erhvervsstyrelsen.dk/klagenaevnet-for-udbud
\n
Denne organisations roller:
Organisation med ansvar for klager
\n
\n
\n
8.1 ORG-0003
Officielt navn: Konkurrence- og Forbrugerstyrelsen
\n
Registreringsnummer: ORG-10294819
\n
Postadresse: Carl Jacobsens Vej 35  
\n
By: Valby
\n
Postnummer: 2500
\n
Landespecifik underafdeling (NUTS): Byen København (DK011)
\n
Land: Danmark
\n
Kontaktpunkt: Konkurrence- og Forbrugerstyrelsen
\n
E-mail: kfst@kfst.dk
\n
Telefon: +45 41715000
\n
Adresse til udveksling af oplysninger (URL): https://www.kfst.dk
\n
Denne organisations roller:
Organisation, der leverer yderligere oplysninger om klageprocedurerne
\n
\n
\n
8.1 ORG-0004
Officielt navn: Biorep Technologies, Inc.
\n
Den økonomiske operatørs størrelse: Mellemstor virksomhed
\n
Registreringsnummer: Biorep Technologies, Inc.
\n
By: Miami Lakes
\n
Postnummer: 15804
\n
Land: Forenede Stater
\n
E-mail: sales@biorep.com
\n
Telefon: 305 330 4449
\n
Denne organisations roller:
Tilbudsgiver
\n
Vinder af disse delkontrakter: LOT-0000
\n
\n
\n
8.1 ORG-0005
Officielt navn: Mercell Holding ASA
\n
Registreringsnummer: 980921565
\n
Postadresse: Askekroken 11  
\n
By: Oslo
\n
Postnummer: 0277
\n
Landespecifik underafdeling (NUTS): Oslo (NO081)
\n
Land: Norge
\n
Kontaktpunkt: eSender
\n
E-mail: publication@mercell.com
\n
Telefon: +47 21018800
\n
Fax: +47 21018801
\n
Internetadresse: http://mercell.com/
\n
Denne organisations roller:
TED eSender
\n
\n
\n
\n
11 Oplysninger om bekendtgørelsen
11.1 Oplysninger om bekendtgørelsen
Identifikator for bekendtgørelsen: 05bba3f0-aa33-431a-b47f-d4d8252fbac2 - 01
\n
Formulartype: Resultater
\n
Bekendtgørelsestype: Bekendtgørelse om indgåede kontrakter eller koncessionstildeling – standardordningen
\n
Afsendelsesdato for bekendtgørelsen: 28-05-2024 09:31 +00:00
\n
Dato for afsendelse af bekendtgørelse (eSender): 28-05-2024 09:40 +00:00
\n
Sprog, som denne bekendtgørelse er officielt tilgængelig på: engelsk 
\n
\n
11.2 Oplysninger om offentliggørelsen
Bekendtgørelsesnummer: 00317424-2024
\n
EUT-S-nummer: 103/2024
\n
Offentliggørelsesdato: 29-05-2024
\n
\n
\n \n","htmlEN":"\n\n \n
1 Buyer
1.1 Buyer
Official name: Aarhus Universitet
\n
Legal type of the buyer: Body governed by public law
\n
Activity of the contracting authority: Education
\n
\n
\n
2 Procedure
2.1 Procedure
Title: 2024-0666349 - Perifusion System
\n
Description: The Department of Biomedicine at Aarhus University intends to buy the PERI5-115/230\n - AUTOMATED PERIFUSION SYSTEM for the reasons listed below. The PERI5-115/230 - AUTOMATED\n PERIFUSION SYSTEM instrumentation holds advanced features including high-resolution\n infusion capacity, real-time monitoring capabilities, customizable experimental setups,\n and compatibility with various laboratory protocols/assays. These specifications are\n crucial for our research and experimental endeavors, as they enable us to accurately\n measure and analyze physiological parameters with utmost precision and efficiency\n related to our research interests in studying kidney disease.The advanced specifications\n offered by the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation are necessary\n for our laboratory due to the intricate nature of our research projects and the critical\n need for reliable precise drug delivery or precise incubation conditions. Without\n these features, we would face significant limitations in our ability to accurately\n study and understand complex physiological phenomena, potentially impeding our progress\n and hindering the advancement of our scientific objectives.To the best of our knowledge,\n no alternative suppliers have come to our attention, the distinctive combination of\n features, quality, and expertise encapsulated in the PERI5-115/230 - AUTOMATED PERIFUSION\n SYSTEM instrumentation from Biorep Technologies, Inc. that can fulfil our needs. The\n conclusion drawn from our analysis is that, given the absence of viable alternatives\n known to us, Biorep Technologies, Inc. is the optimal and only choice to fulfil our\n requirements, providing us with the necessary tools and support to advance our research\n endeavours successfully.
\n
Procedure identifier: fb84f75e-f84e-4ba2-bd14-66b9984b836c
\n
Previous notice: 4ddd65eb-1793-47d1-ad17-e9460e7de914-01
\n
Internal identifier: 2024-0666349
\n
Type of procedure: Negotiated without prior call for competition
\n
2.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 38000000 Laboratory, optical and precision equipments (excl. glasses)
\n
Additional classification (cpv): 38432000 Analysis apparatus
\n
\n
2.1.2 Place of performance
Country subdivision (NUTS): Østjylland (DK042)
\n
Country: Denmark
\n
\n
2.1.4 General information
Call for competition is terminated
\n
Legal basis:
\n
Directive 2014/24/EU
\n
\n
\n
\n
5 Lot
5.1 Lot technical ID: LOT-0000
Title: 2024-0666349 - Perifusion System
\n
Description: The Department of Biomedicine at Aarhus University intends to buy the PERI5-115/230\n - AUTOMATED PERIFUSION SYSTEM for the reasons listed below. The PERI5-115/230 - AUTOMATED\n PERIFUSION SYSTEM instrumentation holds advanced features including high-resolution\n infusion capacity, real-time monitoring capabilities, customizable experimental setups,\n and compatibility with various laboratory protocols/assays. These specifications are\n crucial for our research and experimental endeavors, as they enable us to accurately\n measure and analyze physiological parameters with utmost precision and efficiency\n related to our research interests in studying kidney disease.The advanced specifications\n offered by the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation are necessary\n for our laboratory due to the intricate nature of our research projects and the critical\n need for reliable precise drug delivery or precise incubation conditions. Without\n these features, we would face significant limitations in our ability to accurately\n study and understand complex physiological phenomena, potentially impeding our progress\n and hindering the advancement of our scientific objectives.To the best of our knowledge,\n no alternative suppliers have come to our attention, the distinctive combination of\n features, quality, and expertise encapsulated in the PERI5-115/230 - AUTOMATED PERIFUSION\n SYSTEM instrumentation from Biorep Technologies, Inc. that can fulfil our needs. The\n conclusion drawn from our analysis is that, given the absence of viable alternatives\n known to us, Biorep Technologies, Inc. is the optimal and only choice to fulfil our\n requirements, providing us with the necessary tools and support to advance our research\n endeavours successfully.
\n
Internal identifier: 2024-0666349
\n
5.1.1 Purpose
Main nature of the contract: Supplies
\n
Main classification (cpv): 38000000 Laboratory, optical and precision equipments (excl. glasses)
\n
Additional classification (cpv): 38432000 Analysis apparatus
\n
\n
5.1.2 Place of performance
Country subdivision (NUTS): Østjylland (DK042)
\n
Country: Denmark
\n
Additional information: 
\n
\n
5.1.4 Renewal
Maximum renewals: 0
\n
\n
5.1.6 General information
Procurement Project not financed with EU Funds.
\n
The procurement is covered by the Government Procurement Agreement (GPA): yes
\n
\n
5.1.10 Award criteria
Criterion:
Type: Quality
\n
Description: The instrument is unique
\n
Order of importance: 1
\n
\n
Justification for not indicating the weighting of the award criteria: There is only one supplier of this instrument
\n
\n
5.1.12 Terms of procurement
Information about review deadlines: Please contact Aarhus University, if you have a comment about this notice - udbud@au.dk\n Following the notification, a standstill period of 10 calendar days will be held in\n accordance to paragraph 3 of Act No. 593 of 2 June 2016 on the Danish Act on the Complaints\n Board for public Procurement. This implies that the Contracting Authority cannot sign\n the Contract with the winning Tenderer before the standstill period has expired. In\n case of complaints about tenders or decisions, e.g. award of contracts covered by\n Section II or III in the Danish Public Procurement Act must be submitted to the Complaints\n Board for Public Procurement (Klagenævnet for Udbud) within 45 calendar days from\n the day after the contractor published a notice in the Official Journal on the conclusion\n of a contract. At the latest concurrently with submission of an appeal to the Complaints\n Board for Public Procurement, the complainant must inform the Contracting Authority\n of the alleged infringement, and whether the appeal is to be referred to the board.
\n
\n
5.1.15 Techniques
Framework agreement:
No framework agreement
\n
\n
Information about the dynamic purchasing system:
No dynamic purchase system
\n
\n
\n
5.1.16 Further information, mediation and review
Review organisation: Klagenævnet for udbud
\n
Organisation providing more information on the review procedures: Konkurrence- og Forbrugerstyrelsen
\n
TED eSender: Mercell Holding ASA
\n
\n
\n
\n
6 Results
Value of all contracts awarded in this notice: 511.566 Danish krone
\n
Direct award:
Justification for direct award: The contract can be provided only by a particular economic operator because of an absence of competition for technical reasons
\n
Other justification: The Department of Biomedicine at Aarhus University intends to buy the PERI5-115/230\n - AUTOMATED PERIFUSION SYSTEM for the reasons listed below. The PERI5-115/230 - AUTOMATED\n PERIFUSION SYSTEM instrumentation holds advanced features including high-resolution\n infusion capacity, real-time monitoring capabilities, customizable experimental setups,\n and compatibility with various laboratory protocols/assays. These specifications are\n crucial for our research and experimental endeavors, as they enable us to accurately\n measure and analyze physiological parameters with utmost precision and efficiency\n related to our research interests in studying kidney disease.The advanced specifications\n offered by the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation are necessary\n for our laboratory due to the intricate nature of our research projects and the critical\n need for reliable precise drug delivery or precise incubation conditions. Without\n these features, we would face significant limitations in our ability to accurately\n study and understand complex physiological phenomena, potentially impeding our progress\n and hindering the advancement of our scientific objectives.To the best of our knowledge,\n no alternative suppliers have come to our attention, the distinctive combination of\n features, quality, and expertise encapsulated in the PERI5-115/230 - AUTOMATED PERIFUSION\n SYSTEM instrumentation from Biorep Technologies, Inc. that can fulfil our needs. The\n conclusion drawn from our analysis is that, given the absence of viable alternatives\n known to us, Biorep Technologies, Inc. is the optimal and only choice to fulfil our\n requirements, providing us with the necessary tools and support to advance our research\n endeavours successfully.
\n
\n
6.1 Result lot ldentifier: LOT-0000
At least one winner was chosen.
\n
6.1.2 Information about winners
Winner:
Official name: Biorep Technologies, Inc.
\n
Tender:
\n
Tender identifier: 2024-0666349 - Perifusion System
\n
Identifier of lot or group of lots: LOT-0000
\n
Subcontracting: No
\n
Subcontracting value is known: no
\n
Subcontracting percentage is known: no
\n
Contract information:
Identifier of the contract: 2024-0666349 - Perifusion System
\n
Date of the conclusion of the contract: 14-05-2024
\n
The contract is awarded within a framework agreement: no
\n
\n
\n
\n
6.1.4 Statistical information
Received tenders or requests to participate:
Type of received submissions: Tenders from medium tenderers
Number of tenders or requests to participate received: 1
\n
\n
\n
\n
\n
\n
8 Organisations
8.1 ORG-0001
Official name: Aarhus Universitet
\n
Registration number: ORG-31119103
\n
Postal address: Nordre Ringgade 1  
\n
Town: Aarhus C
\n
Postcode: 8000
\n
Country subdivision (NUTS): Østjylland (DK042)
\n
Country: Denmark
\n
Contact point: Ann Sophie Steffensen
\n
Email: asst@au.dk
\n
Telephone: 23382421
\n
Internet address: https://www.au.dk/
\n
Roles of this organisation:
Buyer
\n
\n
\n
8.1 ORG-0002
Official name: Klagenævnet for udbud
\n
Registration number: ORG-37795526
\n
Postal address: Toldboden 2  
\n
Town: Viborg
\n
Postcode: 8800
\n
Country subdivision (NUTS): Vestjylland (DK041)
\n
Country: Denmark
\n
Contact point: Klagenævnet for udbud
\n
Email: klfu@naevneneshus.dk
\n
Telephone: +45 72405708
\n
Information exchange endpoint (URL): https://erhvervsstyrelsen.dk/klagenaevnet-for-udbud
\n
Roles of this organisation:
Review organisation
\n
\n
\n
8.1 ORG-0003
Official name: Konkurrence- og Forbrugerstyrelsen
\n
Registration number: ORG-10294819
\n
Postal address: Carl Jacobsens Vej 35  
\n
Town: Valby
\n
Postcode: 2500
\n
Country subdivision (NUTS): Byen København (DK011)
\n
Country: Denmark
\n
Contact point: Konkurrence- og Forbrugerstyrelsen
\n
Email: kfst@kfst.dk
\n
Telephone: +45 41715000
\n
Information exchange endpoint (URL): https://www.kfst.dk
\n
Roles of this organisation:
Organisation providing more information on the review procedures
\n
\n
\n
8.1 ORG-0004
Official name: Biorep Technologies, Inc.
\n
Size of the economic operator: Medium
\n
Registration number: Biorep Technologies, Inc.
\n
Town: Miami Lakes
\n
Postcode: 15804
\n
Country: United States
\n
Email: sales@biorep.com
\n
Telephone: 305 330 4449
\n
Roles of this organisation:
Tenderer
\n
Winner of these lots: LOT-0000
\n
\n
\n
8.1 ORG-0005
Official name: Mercell Holding ASA
\n
Registration number: 980921565
\n
Postal address: Askekroken 11  
\n
Town: Oslo
\n
Postcode: 0277
\n
Country subdivision (NUTS): Oslo (NO081)
\n
Country: Norway
\n
Contact point: eSender
\n
Email: publication@mercell.com
\n
Telephone: +47 21018800
\n
Fax: +47 21018801
\n
Internet address: http://mercell.com/
\n
Roles of this organisation:
TED eSender
\n
\n
\n
\n
11 Notice information
11.1 Notice information
Notice identifier/version: 05bba3f0-aa33-431a-b47f-d4d8252fbac2 - 01
\n
Form type: Result
\n
Notice type: Contract or concession award notice – standard regime
\n
Notice dispatch date: 28-05-2024 09:31 +00:00
\n
Notice dispatch date (eSender): 28-05-2024 09:40 +00:00
\n
Languages in which this notice is officially available: English 
\n
\n
11.2 Publication information
Notice publication number: 00317424-2024
\n
OJ S issue number: 103/2024
\n
Publication date: 29-05-2024
\n
\n
\n \n","opsummeringDA":{"card":{"titel":"2024-0666349 - Perifusion System","ordregiver":"Aarhus Universitet","ordregiverId":"ORG-31119103","ordregiverIdDatavasket":"31119103","publiceringsdato":"2024-05-29Z","cpvKode":"38000000","cpvTitel":"Laboratorieudstyr, optisk udstyr og præcisionsudstyr (ikke briller)","formulartype":"Resultater","formulartypeKode":"result","tidsfrister":[],"alleOrdregivere":["Aarhus Universitet"],"beskrivelse":"The Department of Biomedicine at Aarhus University intends to buy the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM for the reasons listed below. The PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation holds advanced features including high-resolution infusion capacity, real-time monitoring capabilities, customizable experimental setups, and compatibility with various laboratory protocols/assays. These specifications are crucial for our research and experimental endeavors, as they enable us to accurately measure and analyze physiological parameters with utmost precision and efficiency related to our research interests in studying kidney disease.The advanced specifications offered by the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation are necessary for our laboratory due to the intricate nature of our research projects and the critical need for reliable precise drug delivery or precise incubation conditions. Without these features, we would face significant limitations in our ability to accurately study and understand complex physiological phenomena, potentially impeding our progress and hindering the advancement of our scientific objectives.To the best of our knowledge, no alternative suppliers have come to our attention, the distinctive combination of features, quality, and expertise encapsulated in the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation from Biorep Technologies, Inc. that can fulfil our needs. The conclusion drawn from our analysis is that, given the absence of viable alternatives known to us, Biorep Technologies, Inc. is the optimal and only choice to fulfil our requirements, providing us with the necessary tools and support to advance our research endeavours successfully.","bkSubTypeKode":"29","bkSubType":"Bekendtgørelse om indgåede kontrakter – det generelle direktiv, standardordningen","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":[],"udforelsesstedNutsCode":["DK042"],"udforelsesstedSubLand":["Østjylland"],"udforelsesstedLand":["Danmark"],"udforelsesstedBy":[],"tilbudsfrister":[],"intressentfrister":[],"deltagelsefrister":[],"antalParts":0,"antalLots":1,"udbudsDokumenter":[]},"opsummeringEN":{"card":{"titel":"2024-0666349 - Perifusion System","ordregiver":"Aarhus Universitet","ordregiverId":"ORG-31119103","ordregiverIdDatavasket":"31119103","publiceringsdato":"2024-05-29Z","cpvKode":"38000000","cpvTitel":"Laboratory, optical and precision equipments (excl. glasses)","formulartype":"Result","formulartypeKode":"result","tidsfrister":[],"alleOrdregivere":["Aarhus Universitet"],"beskrivelse":"The Department of Biomedicine at Aarhus University intends to buy the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM for the reasons listed below. The PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation holds advanced features including high-resolution infusion capacity, real-time monitoring capabilities, customizable experimental setups, and compatibility with various laboratory protocols/assays. These specifications are crucial for our research and experimental endeavors, as they enable us to accurately measure and analyze physiological parameters with utmost precision and efficiency related to our research interests in studying kidney disease.The advanced specifications offered by the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation are necessary for our laboratory due to the intricate nature of our research projects and the critical need for reliable precise drug delivery or precise incubation conditions. Without these features, we would face significant limitations in our ability to accurately study and understand complex physiological phenomena, potentially impeding our progress and hindering the advancement of our scientific objectives.To the best of our knowledge, no alternative suppliers have come to our attention, the distinctive combination of features, quality, and expertise encapsulated in the PERI5-115/230 - AUTOMATED PERIFUSION SYSTEM instrumentation from Biorep Technologies, Inc. that can fulfil our needs. The conclusion drawn from our analysis is that, given the absence of viable alternatives known to us, Biorep Technologies, Inc. is the optimal and only choice to fulfil our requirements, providing us with the necessary tools and support to advance our research endeavours successfully.","bkSubTypeKode":"29","bkSubType":"Contract award notice – general directive, standard regime","erAendring":false},"indholdsType":"HENTET_FRA_TED","sekundaereOrdregivere":[],"udforelsesstedNutsCode":["DK042"],"udforelsesstedSubLand":["Østjylland"],"udforelsesstedLand":["Denmark"],"udforelsesstedBy":[],"tilbudsfrister":[],"intressentfrister":[],"deltagelsefrister":[],"antalParts":0,"antalLots":1,"udbudsDokumenter":[]}}